Obesity
From the Journals
ESG yields significant, sustained weight loss across obesity classes
At 12 months, 83.2% of patients achieved ≥10% TBWL and 60.9% achieved ≥15% TBWL across all obesity classes.
Conference Coverage
Antidepressants ‘don’t blunt’ semaglutide and weight loss
“Semaglutide 2.4 mg provides an effective treatment option for weight management, regardless of antidepressant use at baseline.”
Latest News
Taking a new obesity drug and birth control pills? Be careful
“It [the warning] was in the product insert, but clinically speaking, I don’t know if it was at the top of providers’ minds when they were...
Latest News
Docs weigh in on insurance coverage for obesity medications
“We would not see the spate of coverage restrictions if we were talking about heart disease or cancer; insurers can get away with this because...
From the Journals
Scientists find the ‘on’ switch for energy-burning brown fat
Activating brown fat could trigger “signals that help coordinate whole-body energy metabolism.”
From the Journals
Metformin, weight management to stop type 2 diabetes in kids
“Weight stabilization and metformin therapy could be important interventions for diabetes prevention in children.”
Conference Coverage
New ‘twincretin’ pemvidutide: Another option for obesity
“We need to look at the person holistically and at other aspects of cardiometabolic health and treat in a personalized way and choose treatments...
Conference Coverage
Are they ‘antiobesity medications’ or ‘weight-loss drugs’?
“We believe that the common use of the term ‘weight-loss medications’ by media and the public, as well as by doctors and the scientific community...
Conference Coverage
Semaglutide win in HFpEF with obesity regardless of ejection fraction: STEP-HFpEF
It remains unknown, however, “whether the improvement in health status, functional status, and reduced inflammation” will translate to reduced...
Feature
The new word in liver disease: The story behind NAFLD’s rebranding as MASLD
“There are tons of these patients who were not being considered before. Now they’re in a category by themselves, where they are going to be able...
Conference Coverage
Weight loss with semaglutide maintained for up to 3 years
“Importantly, these effects were sustained for up to 3 years, supporting the use of once weekly semaglutide for the long-term management of type 2...